Salt AI Raises $10 Million in Funding

Salt AI Raises $10 Million in Funding

Salt AI, a Los Angeles, CA-based contextual AI platform for life sciences and health tech, has raised $10 million in funding.

The round was led by Morpheus Ventures, with participation from Struck Capital, Marbruck Investments, and CoreWeave.

Morpheus Ventures is a U.S.-based early-stage venture capital firm that invests in technology companies across a variety of sectors. The firm invests from the Seed to Series A stages, with a focus on disruptive technologies. It is headquartered in Los Angeles, California, with an office in Sydney, Australia.

The company will use the funding to expand its footprint with leading biopharma and healthcare companies and to scale its AI engineering teams.

Led by CEO Aber Whitcomb, Salt AI is a company that provides a contextual AI platform for life sciences and health tech enterprises. The company’s visual-first interface, combined with full-code capabilities, enables pharmaceutical, biotech, and healthcare organizations to design, deploy, and scale AI-powered workflows across the value chain—from drug discovery and clinical development to operations and revenue cycle management. Powered by the Salt Matrix, a catalog of sector-specific data connectors, models, and solutions. Headquartered in Los Angeles, Salt AI partners with global enterprises and research leaders.

Funding Details

Company: Salt AI

Raised: $10.0M

Round: Unknown

Funding Date: September 2025

Lead Investor: Morpheus Ventures

Additional Investors: Struck Capital, Marbruck Investments, CoreWeave

Company Website: https://www.salt.ai/

Software Category: AI for Life Sciences & Health Tech